Cubist Systematic Strategies’s CorMedix CRMD Stock Holding History

Cubist Systematic Strategies’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-415,218	Closed	-$5.12M	–	3086
2025 Q2	$5.12M	Buy	+415,218	New	+$4.58M	0.02%	1010
2025 Q1	–	Sell	-72,354	Closed	-$586K	–	2958
2024 Q4	$586K	Buy	+72,354	New	+$723K	﹤0.01%	2104
2024 Q1	–	Sell	-17,259	Closed	-$64.9K	–	3811
2023 Q4	$64.9K	Buy	17,259 +4,490	+35%	+$15.5K	﹤0.01%	3242
2023 Q3	$47.2K	Buy	+12,769	New	+$50.8K	﹤0.01%	3035
2023 Q2	–	Sell	-29,042	Closed	-$120K	–	3634
2023 Q1	$120K	Buy	+29,042	New	+$119K	﹤0.01%	3401
2022 Q4	–	Sell	-28,000	Closed	-$79K	–	4295
2022 Q3	$79K	Sell	28,000 -10,301	-27%	-$42.9K	﹤0.01%	4064
2022 Q2	$154K	Buy	+38,301	New	+$142K	﹤0.01%	3803

Other funds holding CRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubist Systematic Strategies's CRMD Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of CorMedix (CRMD) in Q3 2025, closing a stake of 415,218 shares — an estimated $5.12M sold.

Cubist Systematic Strategies first reported a position in CRMD in Q2 2022 and held it in 7 quarters. The position peaked at $5.12M in Q2 2025. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

Cubist Systematic Strategies reported no remaining CorMedix position as of Q3 2025 after selling out during the quarter.
Cubist Systematic Strategies sold 415,218 CorMedix shares in Q3 2025, an estimated $5.12M.
Cubist Systematic Strategies first reported a position in CorMedix in Q2 2022 and held it in 7 quarters.
Cubist Systematic Strategies's CorMedix position peaked at $5.12M in Q2 2025.
190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.